,Singapore

SG patients with advanced NSCLC to benefit from monotherapy drug option

Treatment options for NSCLC patients with EGFR mutation can now be accessed.

Patients in Singapore with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR)-activating mutations can now benefit from monotherapy drugs that have shown improvement in progression-free survival and overall survival.

The exon 21 L858R mutation made up 39.3% of total EGFR mutations tested locally between March 2013 to March 2014. Patients with the mutation tend to have a higher tumour mutational burden and shorter overall survival. This is critical for Singapore, where the high disease-attributable mortality of lung cancer makes the condition a public health issue.

"Globally, lung cancer treatment has changed from a histology-based to a target-based approach, as the management of NSCLC patients is becoming increasingly complex," said Icon Cancer Centre Medical Oncology Specialist Daniel Chan. "Since prolongation of survival is a key concern among our patients in Singapore, the addition of monotherapy drug treatments to the current ones is a step forward in the right direction to provide physicians with more options for patients with this disease."

Lung cancer continues to be the leading source of cancer death over the past fifty years. It was the top cause of cancer death among males and the second leading cause of cancer death among females from 2013 to 2017.

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

A white paper recommends a new model for healthcare delivery and financing.
Two companies have bid to make the hospital group private.
The move aims to provide world-class critical care for India.
The two will create a regional and international hub for non-invasive diagnostics in Singapore.
The institute aims to serve as a maternal and child health research centre.
Remote clinics rely heavily on irregular mobile medical services.
The products are part of the Heart Wellness Check-Up programme launched in Bangkok.
But, the companies can decide not to push through with the plan.
The report also shows maintenance cost of equipment has exceeded the cost of new procurement.
The partnership will enable high-potential research on cancer immunotherapy in Asia Pacific.
Bayer held the #TakeControl virtual roundtable on the occasion of World Contraception Day 2021.
This will establish a smart platform for advanced medical treatment.
They are the 35- to 54-year-old adults caring for both parents and children.
Around 66% of Southeast Asians preferring remote video-call consultations with medical professionals.